Effect of sodium-glucose cotransporter-2 inhibitors on kidney outcomes of individuals with type 2 diabetes according to blood pressure levels
This nationwide cohort analysis demonstrated that the kidney-protective effect of SGLT2 inhibitors could be modified by baseline SBP, highlighting the importance of patient selection by assessing their BP.
Authors
- Norihiko Takeda (ORCID: https://orcid.org/0000-0003-1023-6116)
- Yuta Suzuki (ORCID: https://orcid.org/0000-0002-9406-4691)
- Hidehiro Kaneko (ORCID: https://orcid.org/0000-0003-2553-6170)
- Hiroyuki Morita
- Norifumi Takeda (ORCID: https://orcid.org/0000-0003-4818-3347)
- Katsuhito Fujiu
- Masaomi Nangaku (ORCID: https://orcid.org/0000-0001-7401-2934)
- Kaori Hayashi (ORCID: https://orcid.org/0000-0002-4923-1550)
- Takahiro Jimba (ORCID: https://orcid.org/0000-0002-3757-3959)
- Koichi Node (ORCID: https://orcid.org/0000-0002-2534-0939)
- Takashi Yokoo (ORCID: https://orcid.org/0000-0003-1838-7998)
- Akira Okada (ORCID: https://orcid.org/0000-0001-5740-4346)
- Issei Komuro (ORCID: https://orcid.org/0000-0002-0714-7182)
- Hideo Yasunaga (ORCID: https://orcid.org/0000-0002-6017-469X)
- Tatsuhiko Azegami (ORCID: https://orcid.org/0000-0002-4809-5788)
- Toshiyuki Ko (ORCID: https://orcid.org/0000-0002-9043-064X)
Institutions
- Jikei University School of Medicine (JP)
- Saga University (JP)
- Keio University (JP)
- University of Tokyo Health Sciences (JP)
- The University of Tokyo (JP)
- International University of Health and Welfare (JP)
Publication Details
- Journal
- European Journal of Preventive Cardiology
- Published
- 2025-03-17
- DOI
- https://doi.org/10.1093/eurjpc/zwaf156
- Citations
- 1
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 1.29